Formulation and Development of Divalproex Sodium Bi-Layered Tablets using Superdisintegrants and Release Retardant Polymers
Divalproex sodium is considered as the most important antiepileptic drug and widely used for treatment of epilepsy and bi-polar disorders and prophylaxis of migraine. The present work has been done to formulate bi-layered tablet of Divalproex sodium containing immediate release layer and sustained release layer. The FTIR study revealed that there was no interaction between drug and polymer and combination. Both layers were prepared by wet granulation technique as poor flow property exhibited by pure drug. The immediate release layer was formulated by using superdisintegrants and evaluated for physical parameters, disintegration time and in vitro drug release. The optimized immediate release layer (IF6) with highest in vitro release of 98.11 was selected for bi-layered tablet formulation. HPMC K4M and HPMC K100M polymer were used to retard the drug release from sustained release layer in different proportion and combination and evaluated for physical parameter along with in vitro drug release studies. The optimized sustained release layer (SF8) which extends the Divalproex sodium release more than 18 hrs was selected. Finally, bi-layered tablets were prepared by double compression of selected sustained release layer and immediate release layer of Divalproex sodium. The tablets were evaluated for hardness, thickness, weight variation, friability, drug content uniformity and in vitro drug release. All the physical parameters were in acceptable limit of pharmacopeial specification. The stability studies, shown the bi-layer tablet was stable at 40oC / 75% RH for a period of 3 months.
Keywords:Bi-layered tablet, Epilepsy, Wet granulation, Divalproex sodium, Immediate release, sustained release
How to Cite
Gaur K, Tyagi LK, Kori ML, Sharma CS and Nema RK (2011). Formulation and characterization of fast disintegrating tablets of Aceclofenac by using sublimation method. Int JPharm Sci Drug Res 3: 19-23.
Goodman and Gillman (2006). The Pharmaceutical Basic of Therapeutics-11thEd. McGraw-Hill, Medical Publishing Division.
Kumar AH, Kavitha K, Kumar SAK, Kumar MR and Singh SDJ (2013). Novel approach of bilayer tablet technology-A review. Int J Pharm Chem Biol Sci 3: 887-893.
Kumar V, Sharma A, Sharma A, Joshi G and Dhillon V (2011). Recent advances in novel drug delivery system for delivery of anti- hypertensive drugs. Int J Drug Del Res 3: 252-59.
Notari R (1980). Bio pharmaceutics and clinical pharmacokinetics, An Introduction, 3rd Ed., Marcel Dekker Inc. New York 152-54.
Patil SC, Payghan SA and Disouza JI (2011). Formulation and evaluation of oral disintegrating tablet of Lornoxicam. Int J Pharm Bio Archive 2: 1518-20.
Patil SS, Hiremath D, Basha KM and Udupi RH (2012). Design and in-vitro evaluation of gastroretentive bilayer floating tablets of Rosiglitazone Maleate. Int J Pharm Bio Archive 3: 204-12.
Rane DR, Gulve HN, Patil Vasant VV, Thakare VM and Patil VR (2012). Formulation and evaluation of orodispersible tablet of Albendazole. Int Current Pharm J 1: 311.
Reddy P, Rao D and Kumar RK (2013). Bi-layer technology-An emerging trend: A review. Int JRes Dev Pharm Life Sci 2: 404-10.
Shibu BS, Suresh S and Saravanan C (2014). Formulation and evaluation of extended release tablet of Divalproex sodium using different polymers as release retarding agent. Int J Pharm Dev Tec 4: 145-55.
Sridharan R (2002). Epidemiology of epilepsy. Current Sci 82: 664-68.
Sukhavasi S and Kishore VS (2012). Formulation and evaluation of orodispersible tablets of Amlodipine besylate by using Fenugreek seed mucilage and Ocimum basilicum gum. Int Current Pharm J 1: 243.
Vinay K, Prajapati SK, Girish CS, Mahendra S and Neeraj K (2012). Sustained release matrix typedrug delivery system. Int Res J Pharm 1: 934-38.